Lamy Patrick's Form 4 filing
Akero Therapeutics, Inc. (AKRO) · filed Jun 20, 2025
- Accession no.
- 0000950170-25-088206
- Filed
- Jun 20, 2025
- Trade date
- Jun 16, 2025
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $108.3K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lamy PatrickCIK 0001961273 | Officer (Senior VP, Commercial Strategy) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseAcquired | +2,000 | $19.87 | +$39,740 | 34,573 | Direct | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −1,500 | $53.82 | −$80,730 | 33,073 | Direct | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −500 | $55.09 | −$27,545 | 32,573 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseDisposed | −83,182 | $0.00 | $0 | 64,182 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.